Prof. Peter Rossing on diabetes complications

suPARnostic See all

Prof. Peter Rossing on diabetes complications

Patients with type 1 diabetes are prone to develop complications such as kidney or heart disease. Professor Peter Rossing and his group are working on biomarkers that may predict which patients are in risk of developing these complications. Peter talks about their latest work on the risk biomarker suPAR and its predictive abilities. Their study "Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes" were published in Diabetes Care in 2019 (https://care.diabetesjournals.org/content/42/6/1112.long)

suPARnostic See all

suPAR is a biomarker on disease severity and prognosis. suPAR has been...
suPAR is today a routine marker used for accessing disease severity and...
På Hvidovre-Amager Hospital forskes i forbedring af patient behandling. To af...
In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital...
In June 2014, The European Science Open Festival was held in Copenhagen,...
The 5th international suPAR symposium was held in Amsterdam 8 and 9th of May...